$ALLR
Allarity Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Allarity Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ALLR down today? It is at $0.800 (-9.25%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALLR spikes, and full due diligence on ALLR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALLR 27 times in the last 30 days. Create a free account to track $ALLR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ALLR traded in the last session, Friday (last price and move above). Our scanner fired 5 unusual-volume and momentum alerts on ALLR on Friday, peaking at 28.8x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystTherapeutics Granted U.S. Patent for Stenoparib's Clinical Dosing Regimen, with Protection Into 2045, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Graff Jeremy R. Officer | Sold (automatic/other) | -15K 0.09% of company | sold 15% | 80K | $14K at $0.970 | Sep 30, 26 |
Graff Jeremy R. Officer | Other | 39K 0.2% of company | added 72% | 95K | n/a | Sep 30, 26 |
Ervin Jeffrey S Officer | Acquired (grant/award) | +150K 0.9% of company | n/a | 150K | n/a | Jan 28, 26 |
Mclaughlin Gerald W. Director | Acquired (grant/award) | +45K 0.3% of company | added 100% | 70K | n/a | Jan 28, 26 |
Jensen Thomas Officer | Acquired (grant/award) | +200K 1.3% of company | added 50% | 597K | n/a | Jan 28, 26 |
Graff Jeremy R. Officer | Sold (automatic/other) | -18K 0.1% of company | sold 24% | 55K | $21K at $1.18 | Jan 22, 26 |
Graff Jeremy R. Officer | Other | 48K 0.3% of company | added 100% | 73K | n/a | Jan 22, 26 |
Graff Jeremy R. Officer | Acquired (grant/award) | +133K 0.8% of company | added 54% | 382K | n/a | Jan 7, 26 |
Hoeiland Jesper Director | Acquired (grant/award) | +25K 0.2% of company | n/a | 25K | n/a | Jan 7, 26 |
Graff Jeremy R. Officer | Sold (automatic/other) | -15K 0.09% of company | sold 37% | 25K | $23K at $1.58 | Sep 30, 25 |
Graff Jeremy R. Officer | Other | 39K 0.2% of company | n/a | 39K | n/a | Sep 30, 25 |
Jensen Thomas Officer | Acquired (grant/award) | +397K 2.5% of company | n/a | 397K | n/a | Jan 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how ALLR traded in the last session, Friday (last price and move above). Our scanner fired 5 unusual-volume and momentum alerts on ALLR on Friday, peaking at 28.8x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ALLR last traded at $0.800, down 9.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ALLR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALLR 27 times in the last 30 days.
ALLR (Allarity Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $13M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALLR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALLR discussion
Sign in to ask a question or join the discussion.